CASP1 is a target for combination therapy in pancreatic cancer.
Wang X, Chen Z, Nie D, Zeng X, Zhong M, Liu X, Zhong S, Wang L, Liao Z, Chen C, Li Y, Zeng C.
Wang X, et al. Among authors: zeng c, zeng x.
Eur J Pharmacol. 2023 Dec 15;961:176175. doi: 10.1016/j.ejphar.2023.176175. Epub 2023 Nov 8.
Eur J Pharmacol. 2023.
PMID: 37949157